Biotech

All Articles

Boundless Biography creates 'modest' cutbacks 5 months after $100M IPO

.Merely 5 months after protecting a $100 thousand IPO, Limitless Biography is already giving up some...

Halda's $126M will certainly accelerate 'keep and also eliminate' cyst medications

.The preliminary phases of oncology R&ampD aren't except intriguing new modalities, as well as Halda...

Lykos 'remorses' certainly not divulging study offenses along with publisher

.Psychopharmacology has drawn 3 posts regarding midstage professional test records evaluating Lykos ...

Analysts explore Avidity's DMD succeed, disclosing distinctions in data

.Avidity Biosciences satisfied entrepreneurs with stage 1/2 information in Duchenne muscular dystrop...

Actinogen's cortisol blocker falls short stage 2 depression research

.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a phase 2 study in clini...

Bivictrix determines going personal only technique to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have been at the center of numerous a billion-dollar biobuck licens...

TPG leadings up funds to $580M for expenditures across life scientific researches

.Property supervisor TPG, which has actually assisted biotechs such as Sionna Rehabs and Santa Clam ...

Merck quits stage 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT plan has suffered yet another misfortune. Months after shuttering a phase 3 ...

After a hard year, Exscientia folds up into Recursion

.After a year determined by pipeline cuts, the variation of its chief executive officer as well as l...

Cullinan, after $25M deal, hands back bispecific to Port

.Cullinan Rehab was excited enough along with Port BioMed's bispecific invulnerable activator that i...